However, disease-related mutations, protein accumulation, or interaction with other proteins or nucleic acids affect the phase transition properties of TDP-43 and might trigger the formation of irreversible pathological aggregates seen in neurodegenerative diseases (8, 9, 10). Here, TARDBP is linked to neurodegenerative disease.